HUP0002669A2 - Treatment of diabetes with thiazolidinedione and sulphonylurea - Google Patents
Treatment of diabetes with thiazolidinedione and sulphonylureaInfo
- Publication number
- HUP0002669A2 HUP0002669A2 HU0002669A HUP0002669A HUP0002669A2 HU P0002669 A2 HUP0002669 A2 HU P0002669A2 HU 0002669 A HU0002669 A HU 0002669A HU P0002669 A HUP0002669 A HU P0002669A HU P0002669 A2 HUP0002669 A2 HU P0002669A2
- Authority
- HU
- Hungary
- Prior art keywords
- diabetes
- sulphonylurea
- thiazolidinedione
- treatment
- insulin
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 title 1
- 229940123464 Thiazolidinedione Drugs 0.000 title 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical compound OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 229940122199 Insulin secretagogue Drugs 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 231100000489 sensitizer Toxicity 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Diabetes mellitus and conditions associated with it, in a mammal, is treated by administration of an insulin sensitiser and an insulin secretagogue. A pharmaceutical composition comprises the two compounds and a suitable carrier.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9806710.1A GB9806710D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0002669A2 true HUP0002669A2 (en) | 2000-12-28 |
| HUP0002669A3 HUP0002669A3 (en) | 2001-12-28 |
Family
ID=10829475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0002669A HUP0002669A3 (en) | 1998-03-27 | 1998-06-15 | Treatment of diabetes with thiazolidinedione and sulphonylurea |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB9806710D0 (en) |
| HU (1) | HUP0002669A3 (en) |
-
1998
- 1998-03-27 GB GBGB9806710.1A patent/GB9806710D0/en not_active Ceased
- 1998-06-15 HU HU0002669A patent/HUP0002669A3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9806710D0 (en) | 1998-05-27 |
| HUP0002669A3 (en) | 2001-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2294582A1 (en) | Treatment of diabetes with thiazolidinedione and metformin | |
| CA2329004A1 (en) | Combination of insulin sensitizer with anorectic for treating or preventing diabetes | |
| HU9400350D0 (en) | Retard peptides | |
| IN2015DN01132A (en) | ||
| MY124695A (en) | Novel composition and use. | |
| NZ504258A (en) | Exendin 3 and 4 agonist compounds for the treatment of diabetes | |
| PH23014A (en) | Novel insulin derivatives,their use and pharmaceutical agents for the treatment of diabetes mellitus | |
| CY1105254T1 (en) | TREATMENT OF DIABETES WITH A THIAZOLIDINEDIONE, AN INSULIN SECRETAGO AND DIGUANIDIUM | |
| WO2004050115A3 (en) | Combination treatment using exendin-4 and thiazolidinediones | |
| BG104059A (en) | Diabetes treatment with rosiglytazone and insulin | |
| MY125855A (en) | Treatment of diabetes with a thiazolidinedione and sulphonylurea | |
| MY138246A (en) | Treatment of diabetes with thiazolidione and sulphonylurea. | |
| HUP0002669A2 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
| AP2000001735A0 (en) | Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor. | |
| IL162853A0 (en) | The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus | |
| HUP0002668A2 (en) | Treatment of diabetes with thiazolidinedione and metformin | |
| IL143088A0 (en) | A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method | |
| WO2003072019A3 (en) | Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog | |
| HUP0002569A2 (en) | Pharmaceutical compositions for treatment of diabetes containing thiazolidinedione and alpha-glucosidase inhibitors | |
| ECSP982534A (en) | NEW METHOD OF TREATMENT | |
| ECSP982542A (en) | NEW METHOD OF TREATMENT III | |
| YU28700A (en) | Use of thiazolidinediones for the treatment of hyperglycaemia | |
| AP2000001787A0 (en) | Use of thiazolidinediones for the treatment of hyperglycaemia. | |
| ECSP982593A (en) | NEW METHOD OF TREATMENT VI | |
| AP1692A (en) | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |